Literature DB >> 19767569

Cutting edge: HLA-DM functions through a mechanism that does not require specific conserved hydrogen bonds in class II MHC-peptide complexes.

Zemin Zhou1, Kari A Callaway, Dominique A Weber, Peter E Jensen.   

Abstract

HLA-DM catalyzes peptide dissociation and exchange in class II MHC molecules through a mechanism that has been proposed to involve the disruption of specific components of the conserved hydrogen bond network in MHC-peptide complexes. HLA-DR1 molecules with alanine substitutions at each of the six conserved H- bonding positions were expressed in cells, and susceptibility to DM catalytic activity was evaluated by measuring the release of CLIP. The mutants alphaN62A, alphaN69A, alphaR76A, and betaH81A DR1 were fully susceptible to DM-mediated CLIP release, and betaN82A resulted in spontaneous release of CLIP. Using recombinant soluble DR1 molecules, the amino acid betaN82 was observed to contribute disproportionately in stabilizing peptide complexes. Remarkably, the catalytic potency of DM with each beta-chain mutant was equal to or greater than that observed with wild-type DR1. Our results support the conclusion that no individual component of the conserved hydrogen bond network plays an essential role in the DM catalytic mechanism.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767569      PMCID: PMC2912111          DOI: 10.4049/jimmunol.0901663

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

1.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Enhanced catalytic action of HLA-DM on the exchange of peptides lacking backbone hydrogen bonds between their N-terminal region and the MHC class II alpha-chain.

Authors:  Efstratios Stratikos; Don C Wiley; Lawrence J Stern
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

3.  Interaction of HLA-DR with an acidic face of HLA-DM disrupts sequence-dependent interactions with peptides.

Authors:  Achal Pashine; Robert Busch; Michael P Belmares; Jason N Munning; Robert C Doebele; Megan Buckingham; Gary P Nolan; Elizabeth D Mellins
Journal:  Immunity       Date:  2003-08       Impact factor: 31.745

4.  T cells distinguish MHC-peptide complexes formed in separate vesicles and edited by H2-DM.

Authors:  Zheng Pu; Scott B Lovitch; Elizabeth K Bikoff; Emil R Unanue
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

5.  Production of high-titer helper-free retroviruses by transient transfection.

Authors:  W S Pear; G P Nolan; M L Scott; D Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-15       Impact factor: 11.205

6.  Energetic asymmetry among hydrogen bonds in MHC class II*peptide complexes.

Authors:  B J McFarland; J F Katz; C Beeson; A J Sant
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

7.  Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'.

Authors:  Michelle L L Donnelly; Garry Luke; Amit Mehrotra; Xuejun Li; Lorraine E Hughes; David Gani; Martin D Ryan
Journal:  J Gen Virol       Date:  2001-05       Impact factor: 3.891

8.  HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

Authors:  C L Chou; S Sadegh-Nasseri
Journal:  J Exp Med       Date:  2000-12-18       Impact factor: 14.307

9.  Complexes of two cohorts of CLIP peptides and HLA-DQ2 of the autoimmune DR3-DQ2 haplotype are poor substrates for HLA-DM.

Authors:  Elizabeth D Mellins; Ludvig M Sollid; Lars-Egil Fallang; Sujin Roh; Anders Holm; Elin Bergseng; Taejin Yoon; Burkhard Fleckenstein; Arunima Bandyopadhyay
Journal:  J Immunol       Date:  2008-10-15       Impact factor: 5.422

10.  Identification of the lateral interaction surfaces of human histocompatibility leukocyte antigen (HLA)-DM with HLA-DR1 by formation of tethered complexes that present enhanced HLA-DM catalysis.

Authors:  Efstratios Stratikos; Lidia Mosyak; Dennis M Zaller; Don C Wiley
Journal:  J Exp Med       Date:  2002-07-15       Impact factor: 14.307

View more
  31 in total

1.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.

Authors:  Zemin Zhou; Eduardo Reyes-Vargas; Hernando Escobar; Brant Rudd; Alan L Rockwood; Julio C Delgado; Xiao He; Peter E Jensen
Journal:  Eur J Immunol       Date:  2016-01-22       Impact factor: 5.532

3.  Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity.

Authors:  Lili Chen; Eduardo Reyes-Vargas; Hu Dai; Hernando Escobar; Brant Rudd; Jared Fairbanks; Alexander Ho; Mathew F Cusick; Attila Kumánovics; Julio Delgado; Xiao He; Peter E Jensen
Journal:  J Immunol       Date:  2014-06-23       Impact factor: 5.422

4.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

Review 5.  Ancient features of the MHC class II presentation pathway, and a model for the possible origin of MHC molecules.

Authors:  Johannes M Dijkstra; Takuya Yamaguchi
Journal:  Immunogenetics       Date:  2018-10-30       Impact factor: 2.846

Review 6.  HLA-DM: arbiter conformationis.

Authors:  Andrea Ferrante
Journal:  Immunology       Date:  2013-02       Impact factor: 7.397

7.  Susceptibility to HLA-DM protein is determined by a dynamic conformation of major histocompatibility complex class II molecule bound with peptide.

Authors:  Liusong Yin; Peter Trenh; Abigail Guce; Marek Wieczorek; Sascha Lange; Jana Sticht; Wei Jiang; Marissa Bylsma; Elizabeth D Mellins; Christian Freund; Lawrence J Stern
Journal:  J Biol Chem       Date:  2014-07-07       Impact factor: 5.157

8.  A novel method to measure HLA-DM-susceptibility of peptides bound to MHC class II molecules based on peptide binding competition assay and differential IC(50) determination.

Authors:  Liusong Yin; Lawrence J Stern
Journal:  J Immunol Methods       Date:  2014-02-25       Impact factor: 2.303

9.  HLA-DM constrains epitope selection in the human CD4 T cell response to vaccinia virus by favoring the presentation of peptides with longer HLA-DM-mediated half-lives.

Authors:  Liusong Yin; J Mauricio Calvo-Calle; Omar Dominguez-Amorocho; Lawrence J Stern
Journal:  J Immunol       Date:  2012-09-10       Impact factor: 5.422

Review 10.  Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Immunol Rev       Date:  2012-11       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.